A Phase I First-in-Human Study of Nesvacumab (REGN910), a Fully Human Anti-Angiopoietin-2 (Ang2) Monoclonal Antibody, in Patients with Advanced Solid Tumors
Papadopoulos, Kyriakos P, Kelley, Robin Kate, Tolcher, Anthony W, Razak, Albiruni R Abdul, Van Loon, Katherine, Patnaik, Amita, Bedard, Philippe L, Alfaro, Ariceli A, Beeram, Muralidhar, Adriaens, Lieve, Brownstein, Carrie M, Lowy, Israel, Kostic, Ana, Trail, Pamela A, Gao, Bo, DiCioccio, A Thomas, Siu, Lillian L
Published in Clinical cancer research (15.03.2016)
Published in Clinical cancer research (15.03.2016)
Get full text
Journal Article